Christopher J. Coughlin, Director at ALEXION PHARMACEUTICALS INC (ALXN), bought 10,000 shares at $120.79 ($1.2M) on 2018-04-30, disclosed to the SEC on 2018-05-02.
Seasonal purchase ($1.2M) by Director — this insider has traded ALXN in April in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| CNC | BUY | 2022-05-03 | $976K | — | Filing → |
| AGN | BUY | 2018-09-07 | $3.5M | — | Filing → |
| AGN | BUY | 2017-12-05 | $1.6M | — | Filing → |